Beta-blocker therapy and primary angioplasty
نویسندگان
چکیده
منابع مشابه
Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
OBJECTIVES We sought to determine if beta-blocker therapy improves clinical outcomes of acute myocardial infarction (AMI) after successful primary percutaneous coronary intervention (PCI). BACKGROUND We have shown that pre-treatment with beta-blockers has a beneficial effect on short-term clinical outcomes in patients undergoing primary PCI for AMI. It is unknown if beta-blocker therapy after...
متن کاملBeta-Blocker Therapy in Noncardiac Surgery
Perioperative myocardial infarction is a major cause of complications and death among patients undergoing noncardiac surgery. 1 Annually in the United States, approximately 27 million patients are given anesthesia for surgical procedures; of these, approximately 50,000 patients have a perioperative myocardial infarction. 2 The pathophysiology of an acute perioperative myocardial infarction is p...
متن کاملBeta-blocker therapy in non-cardiac surgery.
Perioperative myocardial infarction is a major cause of complications and death among patients undergoing noncardiac surgery. 1 Annually in the United States, approximately 27 million patients are given anesthesia for surgical procedures; of these, approximately 50,000 patients have a perioperative myocardial infarction. 2 The pathophysiology of an acute perioperative myocardial infarction is p...
متن کاملThe Effect of Primary Angioplasty and Drug Therapy in Elderly Patients with Acute Coronary Syndrome
Background & Aims: The aging of the population has caused an increase in the number of elderly people who receive treatment for cardiovascular disease. The prevalence of coronary artery disease is higher in the elderly, and on the other hand, complications after cardiac events are worse in the elderly. The most common cause of death in the elderly is cardiovascular disease. Rapid restoration of...
متن کاملAutonomic dysfunction and beta blocker therapy in Chagas heart disease
In a hamster model of Chagas disease, Pimentel et al. (1) recently found that 1) carvedilol decreased mortality in the acute, but not in the chronic stage and 2) in the chronic stage, carvedilol neither changed the left ventricular diameter and/or function, nor attenuated changes in the resting electrocardiogram (ECG), nor decreased the myocardial collagen content. In contrast, we did not obser...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2004
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2004.03.001